Halma plc

LSE (GBp): Halma plc (HLMA)

Last Price

3,128.00

Today's Change

-24.00 (0.76%)

Day's Change

3,090.00 - 3,140.00

Trading Volume

126,336

Overview

Market Cap

11 Billion

Shares Outstanding

377 Million

Avg Volume

765,095

Avg Price (50 Days)

2821.76

Avg Price (200 Days)

2719.64

PE Ratio

40.10

EPS

0.78

Earnings Announcement

19-Nov-2025

Previous Close

3152.00

Open

3134.00

Day's Range

3090.0 - 3140.0

Year Range

2316.0 - 3342.0

Trading Volume

126,336

Price Change Highlight

1 Day Change

-0.76%

5 Day Change

-5.78%

1 Month Change

4.27%

3 Month Change

16.28%

6 Month Change

12.40%

Ytd Change

15.77%

1 Year Change

19.53%

3 Year Change

64.76%

5 Year Change

38.41%

10 Year Change

315.13%

Max Change

5516.81%

News and Blogs

No result.

Company Profile

Sector: Industrials - Industrials

Industry: Conglomerates

Description:

Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment